6Costa DB, Kobayashi S, Tenen DG, et al. Pooled analysis of the pr- ospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers[J].Lung Cancer, 2007, 58(1): 95-103.
7Paz-Ares L, Souli6res D, Melezinek I, et al. Clinical outcomes in non-s mall-cell lung cancer patients with EGFR mutations: pooled analysis [J].Cell Mol Med, 2010, 14(1-2): 51-69.
